2011 | 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
| CANCER |
2009 | 20대 이하 간세포암종의 증례 : 20세 미만의 젊은 연령에서 발병한 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2020 | A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2012 | Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma | LIVER INTERNATIONAL |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2012 | CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice
| HEPATOLOGY |
2019 | Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
| PLOS ONE |
2016 | Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
| CANCER RESEARCH AND TREATMENT |
2013 | Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
| JOURNAL OF RADIATION RESEARCH |
2014 | Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2013 | Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
1999 | Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2014 | Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2017 | Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
| ONCOTARGET |
2015 | Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014) | LIVER CANCER |
2016 | Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials
| LIVER CANCER |
2019 | Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2020 | Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2018 | Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus | ANNALS OF SURGICAL ONCOLOGY |
2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2014 | Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
| GUT AND LIVER |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2007 | Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2013 | Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2011 | Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2014 | Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. | JOURNAL OF NEURO-ONCOLOGY |
2010 | Identification of proteins indicating radiation-induced hepatic toxicity in cirrhotic rats
| JOURNAL OF RADIATION RESEARCH |
2014 | Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2013 | Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
| PLOS ONE |
2010 | Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2016 | Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
| YONSEI MEDICAL JOURNAL |
2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2013 | Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma
| ONCOTARGETS AND THERAPY |
2014 | Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
| JOURNAL OF RADIATION RESEARCH |
2016 | Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
| ONCOTARGET |
2019 | Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma | DIGESTIVE AND LIVER DISEASE |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2007 | Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma | HEPATOLOGY RESEARCH |
2016 | Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2009 | Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2017 | Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18F-fluoro-2-deoxyglucose positron emission tomography | LIVER INTERNATIONAL |
2011 | Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2014 | Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy | ANNALS OF SURGICAL ONCOLOGY |
2016 | The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
| ONCOTARGET |
2009 | The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2012 | The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma. | LIVER INTERNATIONAL |
2014 | Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma | LIVER INTERNATIONAL |
2017 | Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2011 | Treatment of recurrent hepatocellular carcinoma after liver transplantation | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
2012 | Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2002 | 간세포암에서 유래한 골전이의 방사선치료
| Korean Journal of Hepatology (대한간학회지) |
2006 | 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰
| Korean Journal of Hepatology (대한간학회지) |
2005 | 동시 항암 화학-방사선 요법 후 근치적 간절제술을 시행한 제4기 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구학회지) |
2007 | 동시 항암 화학-방사선 요법 후 근치적 간절제술을 시행한 하대정맥 침습이 있는 진행성 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2008 | 동시 항암화학-방사선 요법 후 근치적 간절제술을 시행한 간세포암 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2006 | 랫드 간경변 모델에서 발현되는 단백질의 탐색
| Korean Journal of Hepatology (대한간학회지) |
2008 | 양측 담관을 침범한 간문부 간세포암을 토모테라피를 이용한 항암화학-방사선 동시요법으로 치료한 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |